Xu C - Search Results

1

Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer.

Hinchcliff EM, Knisely A, Adjei N, Fellman B, Yuan Y, Patel A, Xu C, Westin SN, Sood AK, Soliman PT, Shafer A, Fleming ND, Gershenson DM, Vikram R, Bathala T, Vining D, Ganeshan DM, Lu KH, Sun CC, Meyer LA, Jazaeri AA. Hinchcliff EM, et al. Among authors: xu c. Cancer. 2024 Apr 1;130(7):1061-1071. doi: 10.1002/cncr.35126. Epub 2023 Nov 27. Cancer. 2024. PMID: 38009662 Clinical Trial.

2

Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non-Small Cell Lung Cancer.

Wang Y, Li N, Jiang W, Deng W, Ye R, Xu C, Qiao Y, Sharma A, Zhang M, Hung MC, Lin SH. Wang Y, et al. Among authors: xu c. Clin Cancer Res. 2018 Nov 15;24(22):5744-5756. doi: 10.1158/1078-0432.CCR-18-1489. Epub 2018 Aug 1. Clin Cancer Res. 2018. PMID: 30068711

3

Intelligent multi-modal shear wave elastography to reduce unnecessary biopsies in breast cancer diagnosis (INSPiRED 002): a retrospective, international, multicentre analysis.

Pfob A, Sidey-Gibbons C, Barr RG, Duda V, Alwafai Z, Balleyguier C, Clevert DA, Fastner S, Gomez C, Goncalo M, Gruber I, Hahn M, Hennigs A, Kapetas P, Lu SC, Nees J, Ohlinger R, Riedel F, Rutten M, Schaefgen B, Stieber A, Togawa R, Tozaki M, Wojcinski S, Xu C, Rauch G, Heil J, Golatta M. Pfob A, et al. Among authors: xu c. Eur J Cancer. 2022 Dec;177:1-14. doi: 10.1016/j.ejca.2022.09.018. Epub 2022 Sep 28. Eur J Cancer. 2022. PMID: 36283244

4

A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer.

Xi M, Liao Z, Deng W, Xu C, Komaki R, Blum M, Hofstetter WL, Ho L, Lin SH. Xi M, et al. Among authors: xu c. J Thorac Oncol. 2017 Jun;12(6):1001-1010. doi: 10.1016/j.jtho.2017.03.017. Epub 2017 Mar 27. J Thorac Oncol. 2017. PMID: 28351804 Free article.

5

The emerging field of radiomics in esophageal cancer: current evidence and future potential.

van Rossum PSN, Xu C, Fried DV, Goense L, Court LE, Lin SH. van Rossum PSN, et al. Among authors: xu c. Transl Cancer Res. 2016 Aug;5(4):410-423. doi: 10.21037/tcr.2016.06.19. Transl Cancer Res. 2016. PMID: 30687593 Free PMC article.

6

Contrast of Digital and Health Literacy Between IT and Health Care Specialists Highlights the Importance of Multidisciplinary Teams for Digital Health-A Pilot Study.

Pfob A, Sidey-Gibbons C, Schuessler M, Lu SC, Xu C, Dubsky P, Golatta M, Heil J. Pfob A, et al. Among authors: xu c. JCO Clin Cancer Inform. 2021 Jun;5:734-745. doi: 10.1200/CCI.21.00032. JCO Clin Cancer Inform. 2021. PMID: 34236897 Free article.

7

Definitive Chemoradiation Therapy for Esophageal Cancer in the Elderly: Clinical Outcomes for Patients Exceeding 80 Years Old.

Xu C, Xi M, Moreno A, Shiraishi Y, Hobbs BP, Huang M, Komaki R, Lin SH. Xu C, et al. Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):811-819. doi: 10.1016/j.ijrobp.2017.02.097. Epub 2017 Mar 1. Int J Radiat Oncol Biol Phys. 2017. PMID: 28602412

8

Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis.

Xi M, Xu C, Liao Z, Chang JY, Gomez DR, Jeter M, Cox JD, Komaki R, Mehran R, Blum MA, Hofstetter WL, Maru DM, Bhutani MS, Lee JH, Weston B, Ajani JA, Lin SH. Xi M, et al. Among authors: xu c. Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):667-676. doi: 10.1016/j.ijrobp.2017.06.2450. Epub 2017 Jun 27. Int J Radiat Oncol Biol Phys. 2017. PMID: 29280461

9

Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma: a single institutional experience.

Prayongrat A, Xu C, Li H, Lin SH. Prayongrat A, et al. Among authors: xu c. Adv Radiat Oncol. 2017 Jun 13;2(3):301-307. doi: 10.1016/j.adro.2017.06.002. eCollection 2017 Jul-Sep. Adv Radiat Oncol. 2017. PMID: 29114596 Free PMC article.

10

The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy.

Xi M, Xu C, Liao Z, Hofstetter WL, Blum Murphy M, Maru DM, Bhutani MS, Lee JH, Weston B, Komaki R, Lin SH. Xi M, et al. Among authors: xu c. Radiother Oncol. 2017 Aug;124(2):318-324. doi: 10.1016/j.radonc.2017.06.019. Epub 2017 Jul 4. Radiother Oncol. 2017. PMID: 28687396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24,935 results

Search Page